Low dose Amisulpride for very late onset schizophrenia-like psychosis: the ATLAS study

kiwihug-393309-unsplash

Elwira Lubos summarises the recent ATLAS RCT of antipsychotic treatment for very late-onset schizophrenia-like psychosis, which provides evidence for the effectiveness of a very low dose of Amisulpride (100 mg).

[read the full story...]

How does age at onset affect outcomes in schizophrenia?

sergei-solovev-180113

Geoff Davies publishes his debut elf blog about a recent systematic review and meta-analysis looking at age at onset and the outcomes of schizophrenia.

[read the full story...]

No good quality research to guide the treatment of late-onset schizophrenia

shutterstock_919124

Late-onset schizophrenia is relatively common. Onset after the age of 40 years is reported in 23% of patients hospitalised with schizophrenia. The condition is different from early-onset schizophrenia on a number of counts, including the response to antipsychotic drugs. This Cochrane review set out to assess the effects of antipsychotic drugs for elderly people with [read the full story…]